DarDoc Research

GLP-1 Trial & Approval Tracker

GLP-1 pipeline in the UAE

See UAE regulatory decisions, local trial sites and the latest on new strengths.

5 milestones · 3 programmes

Upcoming windows

  1. Estimated
    Trial milestoneUAE trial site

    Foundayo · Eli Lilly

    ACHIEVE-RAM primary completion

    Details

    Registry estimate for a phase 3 study in people with type 2 diabetes who fast during Ramadan. It lists seven UAE sites, including Emirates Hospital Dubai and Dubai Hospital.

    Source

Recorded milestones

  1. ApprovalUAE

    Foundayo · Eli Lilly

    Foundayo gains a type 2 diabetes indication

    Details

    The Emirates Drug Establishment announced a new indication for adults with type 2 diabetes.

    Source
  2. ApprovalUAE

    Wegovy tablets · Novo Nordisk

    Wegovy tablets approved

    Details

    The Emirates Drug Establishment announced oral semaglutide approval for weight management and cardiovascular risk reduction in eligible adults.

    Source
  3. Trial milestoneUAE trial sites

    Mounjaro · Eli Lilly

    Tirzepatide Ramadan study reached primary completion

    Details

    This Ramadan study enrolled people with type 2 diabetes. The registry lists UAE sites including Tawam Hospital, Dubai Hospital and Emirates Hospital Dubai.

    Source
  4. ApprovalUAE

    Foundayo · Eli Lilly

    Foundayo approved for weight management

    Details

    The Emirates Drug Establishment announced orforglipron’s weight-management approval.

    Source

The pipeline covers selected programmes and markets. Estimated primary completion is when a trial expects to finish collecting data for its main outcome. Results and regulatory decisions have separate dates.